← Back to Knowledge Base

Primary topic: SLC37A4 gene blood-sugar regulation

SLC37A4 Gene and Metabolism: What It Can Mean in a Pathway Report

SLC37A4 is tracked because it connects to meal response, fasting glucose control, insulin signaling, or glucose transport. The current evidence index links this gene to Glucose with 1 SNP and 1 curated claim.

What is the SLC37A4 gene?

Endoplasmic-reticulum glucose-6-phosphate transporter enabling luminal glucose-6-phosphatase access and hepatic fasting glucose output.

How SLC37A4 affects metabolism

When SLC37A4-related function is shifted, the practical effect is interpreted through meal response, fasting glucose control, insulin signaling, or glucose transport. This does not mean the pathway is active or impaired right now; it means the gene can help prioritize what to check next.

What happens when SLC37A4 is altered

Altered SLC37A4 signal should be treated as a DNA-based tendency, not a diagnosis. 1 claim currently passes the report-use gate. The useful question is whether symptoms, labs, and lifestyle context line up with the pathway signal.

Curated SNP evidence for SLC37A4

These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.

Evidence-backed report connection

SLC37A4 currently has 1 curated SNPs, 1 claim-level scores, and 1 claims eligible for pathway scoring.

Open the sample report
rs80356491SLC37A4 c.1042_1043del / Leu348Valfs*531 claims · 2 study rows

transport activity · biallelic or compound-heterozygous SLC37A4 deletion context

Glucose-6-phosphate transporter activity tendency

Strong

rs80356491 / SLC37A4 c.1042_1043del / p.Leu348Valfs*53 is associated with lower glucose-6-phosphate transporter activity and glycogen storage disease Ib metabolic biomarker disruption in recessive or compound-heterozygous contexts.

SLC37A4 rs80356491 is staged as a frameshift glucose-6-phosphate transporter deficiency allele affecting fasting glucose output and lactate, triglyceride, uric-acid, and neutrophil metabolic context.

Likely effectLower transport signal
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence

Common symptoms people report

  • sleepiness or fog after carbohydrate-heavy meals
  • energy swings between meals
  • family or lab concern around glucose markers

Biomarkers to validate

Fasting glucose and HbA1c

Checks baseline blood-sugar control.

Fasting insulin

Helps identify insulin-demand context that glucose alone can miss.

Triglycerides and HDL-C

Adds metabolic context around meal response and insulin resistance.

Where DNA analysis helps

DNA helps decide whether SLC37A4 deserves attention inside the broader Glucose pathway. It is most useful when combined with biomarkers instead of used as a standalone answer.

Example interpretation

SLC37A4 may add context to meal response, fasting glucose control, insulin signaling, or glucose transport, especially when its SNP evidence lines up with other genes in the same pathway.

Suggested validation: Fasting glucose and HbA1c.

What to do next

  • Review the Glucose pathway result before interpreting SLC37A4 on its own.
  • Use relevant biomarkers to confirm whether this DNA tendency is visible in current biology.
  • Treat supplement or nutrition decisions as follow-up steps only after the pattern fits symptoms or labs.

Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.

Get My DNA Report

Related pages